Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin
- 19 August 2005
- journal article
- Published by Wiley in FEBS Letters
- Vol. 579 (22) , 5049-5054
- https://doi.org/10.1016/j.febslet.2005.08.011
Abstract
Resistin has been proposed as a potential link between obesity and insulin resistance. It is also well established that altered metabolism of fatty acids by skeletal muscle can lead to insulin resistance and lipotoxicity. However, little is known about the effect of resistin on long chain fatty acid uptake and metabolism in skeletal muscle. Here we show that treating rat skeletal muscle cells with recombinant resistin (50 nM, 24 h) decreased uptake of palmitate. This correlated with reduced cell surface CD36 content and lower expression of FATP1, but no change in FATP4 or CD36 expression. We also found that resistin decreased fatty acid oxidation by measuring 14CO2 production from [1-14C] oleate and an increase in intracellular lipid accumulation was detected in response to resistin. Decreased AMPK and ACC phosphorylation were observed in response to resistin while expression of ACC and AMPK isoforms was unaltered. Resistin mediated these effects without altering cell viability. In summary, our results demonstrate that chronic incubation of skeletal muscle cells with resistin decreased fatty acid uptake and metabolism via a mechanism involving decreased cell surface CD36 content, FATP1 expression and a decrease in phosphorylation of AMPK and ACC.Keywords
This publication has 34 references indexed in Scilit:
- Mouse and Human Resistins Impair Glucose Transport in Primary Mouse Cardiomyocytes, and Oligomerization Is Required for This Biological ActionJournal of Biological Chemistry, 2005
- Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemiaAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- The AMP-activated protein kinase pathway – new players upstream and downstreamJournal of Cell Science, 2004
- The current biology of resistinJournal of Internal Medicine, 2004
- Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patientsInternational Journal of Obesity, 2004
- Transgenic and Recombinant Resistin Impair Skeletal Muscle Glucose Metabolism in the Spontaneously Hypertensive RatPublished by Elsevier ,2003
- Fatty acid metabolism in obesity and type 2 diabetes mellitusProceedings of the Nutrition Society, 2003
- Regulation of mammalian acetyl-CoA carboxylaseBiochemical Society Transactions, 2002
- Insulin Resistance and Type 2 Diabetes Are Not Related to Resistin Expression in Human Fat Cells or Skeletal MuscleBiochemical and Biophysical Research Communications, 2001
- 5′‐AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP‐activated protein kinase. Studies using bacterially expressed human protein phosphatase‐2Cα and native bovine protein phosphatase‐2AcFEBS Letters, 1995